Closed · W81XWH-14-DMRDP-CRMRP-NMSIRA · CFDA 12.420 · Discretionary

DoD Clinical and Rehabilitative Medicine Neuromusculoskeletal Injuries Research Award

Federal grant opportunity posted by Defense Health Agency Contracting Activity - DHACA, cataloged on Grants.gov.

Varies
Award range
Closed
Status
February 11, 2014
Close date
5
Expected awards

The verdict

DoD Clinical and Rehabilitative Medicine Neuromusculoskeletal Injuries Research Award is a closed discretionary listing from Defense Health Agency Contracting Activity - DHACA that offered Varies by applicant across 5 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 1,795 other opportunities from Defense Health Agency Contracting Activity - DHACA.

Varies
award range
Closed
application status
5
expected awards
12.420
CFDA program

Archived opportunity record

DoD Clinical and Rehabilitative Medicine Neur… is closed (last close February 11, 2014). Check the agency catalog for replacement NOFOs. Defense Health Agency Contracting Activity - DHACA still indexes 1,795 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed February 11, 2014

Posted Oct 25 Closes Feb 11

Est. Total Funding

$8,300,000

Expected Awards

5

Instrument

Grant

Description

The FY14 DMRDP CRMRP Neuromusculoskeletal Injuries Research Award (NMSIRA) supports preclinical research and clinical trials on the functional utility of assistive devices related to the human-device interface, secondary health effects following severe extremity injury, and optimizing rehabilitation and device prescription for patients with severe extremity trauma.To meet the intent of the award mechanism, applications must specifically address one or more of the FY14 DMRDP CRMRP NMSIRA Focus Areas listed below. Applications proposing research outside of the Focus Areas listed below should not be submitted in response to this Program Announcement/Funding Opportunity.• Improving the functional utility of assistive devices related to the human-device interface (prostheses, orthoses, and other assistive devices)o Improvements in prosthetic socket comfort, residual limb health, and functiono Providing proprioceptive and other sensory inputs to the usero Improving user intent control of assistive devices• Improving the ability to predict, identify and reduce secondary health effects that develop after severe primary neuromusculoskeletal injuryo Determining factors that predict development and successful treatment of osteoarthritis, low back pain, or other musculoskeletal conditionso Intervention strategies to diminish falls and decrease fracture risko Strategies to improve treatment and rehabilitation of heterotopic ossification• Optimizing treatment strategies and sequence of progression throughout the rehabilitation process following severe extremity traumao Determining the optimal combination, dose, and timing of rehabilitative techniques to minimize impairments and maximize function and performanceo Objectively guiding prosthetic and/or orthotic prescription to minimize impairments and maximize function and performanceIf the proposed study involves the use of a drug or biologic that has not been approved by the Food and Drug Administration (FDA) for its investigational use, evidence that an Investigational New Drug (IND) exemption application has been submitted or will be submitted within 60 days of award is required. If the proposed study involves an Investigational Device that has not been approved or cleared by FDA for its investigational clinical use, the study may be required to comply with the FDA Investigational Device Exemption (IDE) regulations and evidence that an IDE has been submitted or will be submitted within 60 days of the award date or that the device is exempt from an IDE is required. The Government reserves the right to withdraw funding if the IND or IDE application has not been submitted to the FDA within 60 days of the DoD award date or if the documented status of the IND or IDE has not been obtained within 6 months of the award date.

Catch-all / unrestricted eligibility mark · W81XWH-14-DMRDP-CRMRP-NMSIRA

Grants.gov marks DoD Clinical and Rehabilitative Medicine Neur… with a catch-all / unrestricted eligibility code (Unrestricted / see official listing). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Science and Technology / R&D (ST). This eligibility-code string dominates the Defense Health Agency Contracting Activity - DHACA book (1,791 peers, 100% of 1,796).

Code 99
Unrestricted / see official listing

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

CDMRP Help Desk 301-682-5507

What to do next

DoD Clinical and Rehabilitative Medicine Neur… is closed; use the parent program and agency catalog for the next funding cycle.

  • Browse open federal opportunities in the same category when this listing is closed. Open opportunities
  • Look up CFDA 12.420 across all indexed listings before you commit to this opportunity alone. Eligibility finder
  • Compare award ranges across federal categories before you pick a single CFDA. All categories

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants